Meeting
2013 Breast Cancer Symposium
How accurately can clinicians predict the Oncotype DX DCIS score?
Authors
Sarah Patricia Cate
Beth Israel Medical Center, New York, NY
Sarah Patricia Cate , Alyssa Gillego , Manjeet Chadha , John Rescigno , Paul R. Gliedman , Agnes Radzio , Susan K. Boolbol
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B
Track
Survivorship and Health Policy,Systemic Therapy
Sub Track
Ductal Carcinoma In Situ
Citation
J Clin Oncol 31, 2013 (suppl 26; abstr 90)
DOI
10.1200/jco.2013.31.26_suppl.90
Abstract #
90
Poster Bd #
B10
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Mode of detection of second breast cancers in patients undergoing surveillance after treatment of ductal carcinoma in situ.
First Author: Bethany Waites
Poster
2021 ASCO Annual Meeting
AI-based imaging biomarker in mammography for prediction of tumor invasiveness.
First Author: Hyeonseob Nam
Poster
2021 ASCO Annual Meeting
Representation trends in radiation oncology training programs in the United States.
First Author: Emilie Garcia
Poster
2021 ASCO Annual Meeting
Racial and ethnic representation trends in United States oncology training programs.
First Author: Conner Lombardi